Αποτελέσματα Αναζήτησης
2 Οκτ 2017 · The 5-year survival rates for patients with hilar N1 (station 10), interlobar (station 11), and peripheral N1 (stations 12 to 14) involvement were 39%, 51% and 53%, respectively. Patients with hilar LN metastasis showed a shorter survival period than patients with peripheral LN involvement (P=0.02).
Despite improvements in early diagnosis, advancements in treatment, and dramatic initial response to chemotherapy and radiation, 5-year survival rates for SCLC remain an abysmal 5 to 10%. In patients with lung cancer who are surgical candidates, complete surgical resection remains the best option for cure.
1 Ιαν 2003 · The histopathological type of lung cancer correlates with tumour behaviour and prognosis. Staging based on prognosis is essential in clinical trials comparing different management strategies, and enables universal communication regarding the efficacy of different treatments in specific patient groups.
1 Ιαν 2011 · Lung cancer is the leading cause of cancer mortality in both men and women in the United States. 1 Staging plays a critical role in guiding treatment selection and determining prognosis of cancer. Additionally, the evaluation of the response to treatment and the clinical research of cancer are facilitated by a universal system.
23 Ιουν 2021 · Moreover, sublobar resection, particularly segmentectomy, is considered a definitive surgery for small lung cancers, with non-inferior prognosis and better postoperative lung function than lobectomy [6].
18 Αυγ 2016 · Molecular prognostication in lung cancer is an exploding area of research where interest has moved beyond TNM stage and into individualized genetic tumor analysis with immunohistochemistry, microarray, and mutation profiles.
We investigated the prognostic significance of segmental and subsegmental (level 13 and 14) lymph nodes metastasis in patients with resected non-small cell lung cancer (NSCLC).
